CRx-501

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCRx-501
Drug Alias NameCRx-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsAdenosine A2a receptor agonists
TargetsBeta-2 adrenergic receptorAdenosine A2a receptor
Therapy Area/IndicationsMultiple MyelomaLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCombinatorx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCombinatorx
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A